Apixaban versus warfarin in patients with atrial fibrillation - The New England Journal of Medicine - 2011
Brief Summary:
In patients with nonvalvular atrial fibrillation and at ≥1 risk factor, apixaban is associated with a greater reduction in rates of stroke or systemic embolism while having a lower rate of lower bleeding than warfarin.Reference: http://www.ncbi.nlm.nih.gov/pubmed/21870978
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you